PellePharm, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Menlo Park CA United States (2012)

Organization Overview

First Clinical Trial
2016
NCT02762084
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

PellePharm, Inc.